Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study
Journal of Lipid and Atherosclerosis · 2023 · 12 (2) · 201
DOI: 10.12997/jla.2023.12.2.201 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Lipid and Atherosclerosis, 2023. Verfasst von Kye-Yeung Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Hanyang University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Green Cross Biopharma.
Abstract (Originalsprache)
Objective
We aimed to investigate the longitudinal trends in prevalence of hypertriglyceridemia in Korean adults and hypertriglyceridemia-associated lifestyle habits, socioeconomic factors and comorbidities.
Methods
Data from the 2007-2020 Korea National Health and Nutrition Examination Survey (KNHANES) were used in this study. Two cutoff values (≥150 mg/dL and ≥200 mg/dL) for fasting serum triglyceride levels were used to estimate the age- and sex-specific prevalence of hypertriglyceridemia. Use of lipid-lowering medications, lifestyle factors such as smoking, alcohol consumption, and regular exercise, socioeconomic variables such as educational attainment and household income, and comorbidities such as obesity, abdominal obesity, hypertension, and diabetes mellitus were also investigated.
Results
The prevalence of hypertriglyceridemia among Koreans based on KNHANES 2007-2020 was 29.6% at ≥150 mg/dL and 16.1% at ≥200 mg/dL. While the rate of using lipid-lowering medications increased steadily from 2007 to 2020, changes in annual prevalence of hypertriglyceridemia were subtle. The prevalence of hypertriglyceridemia in men peaked in middle age (47.7% and 30.0% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 40s), but its prevalence in women increased throughout their lifetime (32.6% and 14.7% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 70s). Smoking and high-risk drinking exacerbated peak prevalence in both sexes. Young adults with any comorbidities had prominently increased prevalence of hypertriglyceridemia. The lowest levels of education and income were both associated with the higher prevalence of hypertriglyceridemia in both sexes.
Conclusion
It is important to understand the age- and sex-specific epidemiology of hypertriglyceridemia to establish its appropriate management plans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, Hanyang University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
- Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
- Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
ORCID-Profile: Kye-Yeung Park, Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
Förderung
- Green Cross Biopharma
Zitieren
APA
Park, K. Y., Hong, S., Kim, K. S., Han, K., & Park, C. Y. (2023). Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study. Journal of Lipid and Atherosclerosis, 12(2), 201. https://doi.org/10.12997/jla.2023.12.2.201
Vancouver
Park KY, Hong S, Kim KS, Han K, Park CY. Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study. Journal of Lipid and Atherosclerosis. 2023;12(2):201. doi:10.12997/jla.2023.12.2.201
BibTeX
@article{Park2023,
author = {Park, Kye-Yeung and Hong, Sangmo and Kim, Kyung-Soo and Han, Kyungdo and Park, Cheol-Young},
title = {Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study},
journal = {Journal of Lipid and Atherosclerosis},
year = {2023},
volume = {12},
number = {2},
pages = {201},
doi = {10.12997/jla.2023.12.2.201}
}
EUVIMED